Is New Hampshire Breast Cancer Coalition Legit?

The New Hampshire Breast Cancer Coalition demonstrates consistent financial stability with a healthy asset base relative to its annual revenue, reporting $200,025 in assets against $134,686 in revenue for 2023. The organization has maintained zero liabilities across all reported periods, indicating strong fiscal management and no reliance on debt. While specific program spending percentages are not provided in the summary data, the absence of officer compensation across all filings suggests a volunteer-driven leadership, which can significantly reduce administrative overhead and maximize funds for its mission. However, without detailed expense breakdowns, it's challenging to fully assess spending efficiency beyond the lack of executive pay. The organization's revenue has fluctuated over the years, with a notable peak of $195,568 in 2016, but has generally remained in the $70,000-$135,000 range in recent years. In 2023, expenses ($140,715) slightly exceeded revenue ($134,686), leading to a modest decrease in assets from the prior year's $206,054. This slight deficit is not alarming given the overall financial health and asset cushion. The consistent reporting of zero officer compensation across all 13 filings is a significant indicator of transparency and a commitment to directing funds towards the cause rather than executive salaries.